NRLPA:OINN

Insurers shun FTX-linked crypto firms as contagion risk mounts

Dec 19 (Reuters) – Insurers are denying or limiting coverage for customers exposed to bankrupt crypto exchange FTX, leaving traders and digital currency exchanges uninsured against losses from hacking, theft or lawsuits, said several market participants. Insurers were already reluctant to underwrite asset and directors and officers (D&O) protection policies for crypto companies due to …

Insurers shun FTX-linked crypto firms as contagion risk mounts Read More »

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval

Signage is seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Join now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved Bluebird Bio’s (BLUE.O) gene therapy for patients with a rare disease …

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval Read More »

Scroll to Top